Ondine Biomedical Inc (LON:OBIMF) | WebDisclosure

Basculer en Français

11088	Companies
243611	Keywords
171754	Articles
131228	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

PRESS RELEASE

published on 04/15/2024 at 08:00, 2 years 5 months ago

Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available

Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF

published on 04/10/2024 at 08:05, 2 years 5 months ago

Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities

Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
BRIEF

published on 04/10/2024 at 08:05, 2 years 5 months ago

Steriwave d'Ondine Biomedical Inc. autorisé à être utilisé dans les établissements HCA Healthcare au Royaume-Uni

Steriwave Infections Nosocomiales Résistance Aux Antimicrobiens HCA Healthcare Royaume-Uni Réduction Des Antibiotiques
PRESS RELEASE

published on 04/10/2024 at 08:00, 2 years 5 months ago

Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK
HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities

Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF

published on 04/04/2024 at 08:05, 2 years 5 months ago

Ondine Biomedical Inc. Expands into ICU Market with Steriwave®

Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
BRIEF

published on 04/04/2024 at 08:05, 2 years 5 months ago

Ondine Biomedical Inc. se développe sur le marché des soins intensifs avec Steriwave®

Steriwave Ondine Biomedical Infections Nosocomiales Résistance Aux Antimicrobiens Unité De Soins Intensifs
PRESS RELEASE

published on 04/04/2024 at 08:00, 2 years 5 months ago

Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential
Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected

Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF

published on 03/25/2024 at 08:05, 2 years 6 months ago

Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
BRIEF

published on 03/25/2024 at 08:05, 2 years 6 months ago

Ondine Biomedical Inc. parvient à l'adoption commerciale de Steriwave dans les hôpitaux du NHS

Steriwave Infections Du Site Opératoire NHS Ondine Biomédicale Inc. Résistance Aux Antimicrobiens
PRESS RELEASE

published on 03/25/2024 at 08:00, 2 years 6 months ago

Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS
NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption

Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections

Accesswire

Published on 09/29/2026 at 06:45, 1 hour 56 minutes ago

Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Published on 09/29/2026 at 04:36, 4 hours 5 minutes ago

The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)
Published on 09/29/2026 at 02:30, 6 hours 11 minutes ago

QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win
Published on 09/29/2026 at 00:00, 8 hours 41 minutes ago

Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/28/2026 at 23:00, 9 hours 41 minutes ago

CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives

View all ACCESSWIRE

EQS Group

Published on 09/29/2026 at 08:30, 11 minutes ago

2G Energy AG again secures orders exceeding EUR 400 million in the third quarter
Published on 09/29/2026 at 08:10, 30 minutes ago

Segway Powersports Brings Latin American and Canadian Media and Creators from Factory Floor to Real-World Terrain
Published on 09/29/2026 at 08:05, 35 minutes ago

EPAM Ranks #1 for Satisfaction and Delivery in 2026 Swiss Whitelane Research Study
Published on 09/29/2026 at 08:05, 35 minutes ago

One of Germany's Leading Veterinary Networks Chooses CoVet AI to Modernize Clinical Documentation
Published on 09/29/2026 at 08:00, 41 minutes ago

Photon Energy N.V. Commissioned EY-P as an Independent Business Review Provider

Les Echos

Published on 09/28/2026 at 17:54, 14 hours 46 minutes ago

Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 14 hours 46 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 14 hours 56 minutes ago

Weekly share buyback
Published on 09/28/2026 at 17:45, 14 hours 56 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 09/28/2026 at 17:35, 15 hours 6 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026

View all LES ECHOS COMFI WIRE